S Miyaguchi1, T Watanabe. 1. Department of Medicine, Tokyo Metropolitan Otsuka Hospital, Japan.
Abstract
BACKGROUND/AIMS: 1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] exhibits effects on cell proliferation and differentiation. METHODOLOGY: We examined the anti-proliferative effect of 1,25-(OH)2D3 on human hepatocellular carcinoma cell lines (PLC/PRF/5, HCC-T) and the role of vitamin D receptors in modulating this effect. We also investigated the gene expression of vitamin D receptors in tissues from patients with hepatocellular carcinoma. RESULTS: 1,25-(OH)2D3 inhibited proliferation of PLC/PRF/5 cells that express prominent vitamin D receptor mRNA with time and dose dependent manner. On the other hand 1,25-(OH)2D3 had no anti-proliferative effect on hepatocellular carcinoma T cells in which gene expression of vitamin D receptor was little. We next examined vitamin D receptor gene expression in surgically obtained 10 hepatocellular carcinoma tissues by reverse transcriptase-polymerase chain reaction analysis. In all 10 cases, the level of vitamin D receptor mRNA in tumorous tissue was expressed on tumorous tissue. CONCLUSIONS: These results indicate that 1,25-(OH)2D3 may clinically exert its anti-proliferative effect through vitamin D receptors.
BACKGROUND/AIMS: 1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] exhibits effects on cell proliferation and differentiation. METHODOLOGY: We examined the anti-proliferative effect of 1,25-(OH)2D3 on humanhepatocellular carcinoma cell lines (PLC/PRF/5, HCC-T) and the role of vitamin D receptors in modulating this effect. We also investigated the gene expression of vitamin D receptors in tissues from patients with hepatocellular carcinoma. RESULTS:1,25-(OH)2D3 inhibited proliferation of PLC/PRF/5 cells that express prominent vitamin D receptor mRNA with time and dose dependent manner. On the other hand 1,25-(OH)2D3 had no anti-proliferative effect on hepatocellular carcinoma T cells in which gene expression of vitamin D receptor was little. We next examined vitamin D receptor gene expression in surgically obtained 10 hepatocellular carcinoma tissues by reverse transcriptase-polymerase chain reaction analysis. In all 10 cases, the level of vitamin D receptor mRNA in tumorous tissue was expressed on tumorous tissue. CONCLUSIONS: These results indicate that 1,25-(OH)2D3 may clinically exert its anti-proliferative effect through vitamin D receptors.
Authors: Alexis García; Yu Zeng; Sureshkumar Muthupalani; Zhongming Ge; Amanda Potter; Melissa W Mobley; Chakib Boussahmain; Yan Feng; John S Wishnok; James G Fox Journal: Cancer Res Date: 2011-02-18 Impact factor: 12.701
Authors: Robert Wieder; Steven C Novick; Bruce W Hollis; Margarette Bryan; Suzanne M Chanel; Kate Owusu; Danielle Camastra; Tracie Saunders; Lillian Pliner; Jonathan Harrison; Peter Bonate; Tom Williams; Steven Soignet Journal: Invest New Drugs Date: 2003-11 Impact factor: 3.850
Authors: K Dalhoff; J Dancey; L Astrup; T Skovsgaard; K J Hamberg; F J Lofts; O Rosmorduc; S Erlinger; J Bach Hansen; W P Steward; T Skov; F Burcharth; T R J Evans Journal: Br J Cancer Date: 2003-07-21 Impact factor: 7.640